Ivan Fong - Medtronic PLC Gen VP
| 2M6 Stock | EUR 77.10 0.17 0.22% |
Insider
Ivan Fong is Gen VP of Medtronic PLC
| Age | 62 |
| Phone | 353 1 438 1700 |
| Web | https://www.medtronic.com |
Medtronic PLC Management Efficiency
The company has return on total asset (ROA) of 0.0449 % which means that it generated a profit of $0.0449 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0784 %, meaning that it generated $0.0784 on every $100 dollars invested by stockholders. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jennifer OlsonWilk | Align Technology | 45 | |
| Melissa Brotz | Abbott Laboratories | N/A | |
| Hubert Allen | Abbott Laboratories | 57 | |
| Robert Cohen | Stryker | N/A | |
| Daniel Salvadori | Abbott Laboratories | 44 | |
| Jeffrey Mirviss | Boston Scientific | 57 | |
| James Young | Abbott Laboratories | N/A | |
| John Sorenson | Boston Scientific | 55 | |
| Dirksen Lehman | Edwards Lifesciences | N/A | |
| Joseph Hogan | Align Technology | 66 | |
| Elisabeth Staudinger | Siemens Healthineers AG | 53 | |
| Marc Koebernick | Siemens Healthineers AG | N/A | |
| Christopher Toth | Siemens Healthineers AG | 44 | |
| Todd Brinton | Edwards Lifesciences | N/A | |
| Daniel Brennan | Boston Scientific | 57 | |
| Simon Beard | Align Technology | 56 | |
| Zelko Relic | Align Technology | 58 | |
| Alan Douville | Stryker | N/A | |
| Jochen Schmitz | Siemens Healthineers AG | 57 | |
| Jonathan Monson | Boston Scientific | N/A | |
| Shirley Stacy | Align Technology | N/A | |
Management Performance
| Return On Equity | 0.0784 | |||
| Return On Asset | 0.0449 |
Medtronic PLC Leadership Team
Elected by the shareholders, the Medtronic PLC's board of directors comprises two types of representatives: Medtronic PLC inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medtronic. The board's role is to monitor Medtronic PLC's management team and ensure that shareholders' interests are well served. Medtronic PLC's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medtronic PLC's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sean Lennon, Chief Officer | ||
| Jennifer Kirk, Global Officer | ||
| Geoffrey Martha, Executive Vice President and President - Restorative Therapies Group | ||
| Robert White, Executive Vice President and President of Medtronic’s Minimally Invasive Therapies Group | ||
| Ryan Weispfenning, Vice President - Investor Relations | ||
| Robert Hoedt, Executive Vice President and President - EMEAC | ||
| Mark Ploof, Sr Services | ||
| Ivan Fong, Gen VP | ||
| MSc MD, Medical Scientific | ||
| Karen Parkhill, CFO, Executive Vice President |
Medtronic Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medtronic PLC a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0784 | |||
| Return On Asset | 0.0449 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 113.84 B | |||
| Shares Outstanding | 1.33 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 84.51 % | |||
| Price To Earning | 26.98 X | |||
| Price To Book | 1.99 X |
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Medtronic Stock please use our How to Invest in Medtronic PLC guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.